Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Sal Milani who wrote (9403)	6/9/1998 6:56:00 AM
From: DaiS	Read Replies (2) \| Respond to of 23519

Sal, If 42000 try muse I think this is too optimistic for reasons already given by others on the thread. Let's say 20% of 84000 instead 1. 20% of 84000 is 17000 2. It works for 50% gives 8500 3. Of those it works for 10% stick to it (dropouts/cures?) gives 850 By being not unreasonably cautious the recruitment can be reduced to 1%. I would like some more comment from the physicians on this thread about 3. To me the script data suggests a recruitment of 10% - of course some 'dropouts' might be temporary cures. They must surely know from their experiences. DaiS